DXA Quality Assurance Services
With the acquisition of the DXA Resource Group (DRG), M2S has expanded its clinical trials offering and expertise. DXA (Dual-Energy
X-Ray Absorptiometry) is currently the most commonly used technique for measuring bone mineral density and body composition (fat and lean mass). It is used extensively in clinical trials for measuring the safety and efficacy of drugs affecting bone, fat and lean mass. The low radiation dose and quick scan time allows for a variety of research applications.
The M2S Difference:
-
Experienced and dedicated project management ensures proactive and responsive service
- Web-based image upload system saves time and reduces costs
- Quick turn-around time for data review, query resolution, and image analysis
- Manufacturer software integrated within DXA processing application reduces errors by eliminating all manual processing steps
- 21 CFR Part 11 compliant data processing, tracking, and results database
- Standardized results database eliminates the need for study sponsors to reconcile results from various DXA manufacturers
- Real-time web-based reporting saves time and reduces cost by making study information continuously available to relevant parties
Therapeutic Areas that use DXA:
- Osteoporosis
- HIV and HIV therapies
- Obesity
- Diabetes
- Rheumatoid arthritis
- Growth hormone deficiency
- Celiac, Crohn's, Cushing's and Gaucher's disease
- Muscular dystrophy
About DXA Resource Group (DRG):
DRG was founded by individuals with over 50 years of combined experience in DXA. The company focused on providing DXA quality assurance services with a compliant processing application. M2S acquired DRG in December 2008, expanding its clinical trial services to include consultation and analysis of DXA in efficacy and safety trials around the globe.
